Title: A study of plasma Cystatin C as a marker of nephropathy in diabetes mellitus in a Tertiary Care Hospital
Author: Dr V Praveena
DOI: https://dx.doi.org/10.18535/jmscr/v7i9.103
Abstract
Diabetes mellitus continues to evolve as a global public health problem. Early identification of renal functions is important for diabetic patients. Serum Cystatin C may be one of the sensitive indicators of GFR. We in the present study tried to evaluate the usefulness and sensitivity of Cystatin C and creatinine in patients with diabetes mellitus type 2 in comparison with controls.
Methods: The present study was conducted in the Departments of General Medicine and Biochemistry, ESIC Medical College and Hospital, Hyderabad from April 2016 to May 2018. A total of n=88 patients divided into two groups Group I (DM type II) n=44 and Group II (normal controls) n=44 were included in the study. The group I patients was subdivided into three subgroups based on the albuminuria. The subgroup [A] were the patients with microalbuminruia n=13, Subgroup [B] were patients with macroalbuminruia n= 17, Subgroup [C] were patients with normoalbuminuria n=14.
Results: In group I the mean age was 57.5 ± 3.5 years and the Mean age in the control group II was 55.5 ± 2.5 years. Cystatin C was more sensitive then creatinine in microalbumin subgroup [A] urea (73.3 and 75.1 % respectively) in Subgroup [B] the values were [63.5 and 69.8 % respectively] in normoalbuminuria subgroup [C] 59.5 and 54.6 % respectively While in control group serum creatinine was slightly more sensitive than the Cystatin C 42.3 and 41.5 % respectively.
Conclusion: it can be concluded that serum Cystatin C is a good marker of renal nephropathy and impaired renal functions in diabetic patients. In the study patients with macroalbuminuria had highest sensitivity with Cystatin C as compared to creatinine. It may be considered as an alternative marker of nephropathy instead of albuminuria in patients with decreased GFR and renal functions.
Keywords: Cystatin C, Diabetic nephropathy, creatinine.
References
- Shetty V, Jain HR, Singh G, Parekh S, Shetty S. Plasma Cystatin C as Marker of Early Renal Impairment in Diabetes Mellitus. Int J Sci Stud 2017; 4(12):1-7.
- Choe JY, Park SH, Kim SK. Serum cystatin C is a potential endogenous marker for the estimation of renal function in male gout patients with renal impairment. Korean Med Sci 2010; 25: 42 48.
- Al-Wakeel JS, Hammad D, Al Suwaida A, Mitwalli AH, Memon NA, Sulimani F. Microvascular and macrovascular complications in diabetic nephropathy patients referred to nephrology clinic. Saudi J Kidney Dis Transpl 2009; 20:77-85.
- Jorge L. Gross, Mirela J. de Azevedo, Sandra P. Silveiro, Luís Henrique Canani, Maria, Luiza Caramori. 2005. diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 2005; 28(1): 164 176.
- Huda J Waheed. A Comparative Study for Cystatin C and Some Biochemical Markers for Predicting Diabetic Nephropathy in Iraqi Patients Int J Curr Microbiol App.Sci 2015; 4(3): 108-114.
- I H de Boer, T C Rue, PA Cleary et al. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the diabetes control and
complications trial/epidemiology of diabetes interventions and complications cohort. Archives of Internal Medicine 2011; 171(5): 412–20. - KDIGO 2012 clinical practice guideline for evaluation and management of chronic kidney disease. Kidney International Supplements2013; 3(1):1–150.
- Schrijvers BF, De Vriese AS, Flyvbjerg A. From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocrine Reviews. 2004; 25(6):971-10.
- Toyota E, Ogasawara Y, Fujimoto K, Kajita T, Shigeto F, Asano T, et al. Global heterogeneity of glomerular volume distribution in early diabetic nephropathy.
Kidney international. 2004; 66(2):855-61. - Rehman G, Khan SA, Hamayun M. Studies on diabetic nephropathy and secondary diseases in type 2 diabetes. Int J Diab Dev Ctries. 2005;25:25-29.
- Shima T S, Khatun A, Yeasmin F. Cystatin C: A better predictor of kidney function in diabetic patients. Bangladesh J Med Biochem.2011; 4(1): 16 20.
- Tsalamandris C. Allen T J, Gilbert R E, Sinha A, Panagiotopoulos S, Cooper M E, Jerums, G. Progressive decline in renal function in diabetic patients with and without albuminuria. Diabetes1994; 43: 649-55.
- Roos JF, Doust J, Tett SE, Kirkpatrick CM. Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children - A meta-analysis. Clin Biochem 2007;40:383-91.